Kiora Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$12,513,896 over the previous period. Total operating expenses were $12,586,896.
Profit Margin
| 2014 | 0 | -1.77M | |
|---|---|---|---|
| 2015 | 0 | -8.39M | |
| 2016 | 669.25K | -13.34M | -1993.76% |
| 2017 | 407.51K | -13.21M | -3243.52% |
| 2018 | 1.65M | -10.81M | -654.24% |
| 2019 | 2.68M | -7.09M | -264.21% |
| 2020 | 12.05K | -8.09M | -67102.91% |
| 2021 | 0 | -16.39M | |
| 2022 | 0 | -13.58M | |
| 2023 | 0 | -12.51M |
KPRX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 12.05K | 2.68M | 1.65M | 407.51K | 669.25K | 0 | 0 |
Cost of revenue | 4.02M | 134.02K | 227.27K | 200.22K | 4.88K | 0 | 10.33M | 0 | 1.25K | 0 |
Gross profit | -4.02M | -134.02K | -227.27K | -188.16K | 2.68M | 1.65M | -9.92M | 669.25K | -1.25K | 0 |
Operating exp. | ||||||||||
Research and development | 4.02M | 3.44M | 5.35M | 3.56M | 5.38M | 8.05M | 10.33M | 8.42M | 2.71M | 531.11K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 12.58M | 11.72M | 10.67M | 8.22M | 9.79M | 12.49M | 14.96M | 14.01M | 6.67M | 2.46M |
Operating income | -12.58M | -12.30M | -16.94M | -8.18M | -7.00M | -10.84M | -14.55M | -13.34M | -6.67M | -2.46M |
Other income (expenses), net | 163.31K | -1.38M | 242.76K | 19.15K | -325 | 119.32K | -91.70K | 3.40K | 1.00M | 709.81K |
Income before tax | -12.42M | -13.69M | -16.69M | -8.07M | -7.00M | -10.72M | -14.55M | -13.34M | -8.38M | -1.55M |
Income tax expense | 90.31K | -113.01K | -304.78K | 12.05K | 95.39K | 86.04K | -1.34M | 3.68K | 1.93M | 664.20K |
Net income | -12.51M | -13.58M | -16.39M | -8.09M | -7.09M | -10.81M | -13.21M | -13.34M | -8.39M | -1.77M |
Earnings per share | ||||||||||
Basic EPS | -24.25 | -18.55 | -68 | -70.5 | -89.24 | -182.81 | -556.17 | -906.3 | -817.01 | -153.35 |
Diluted EPS | -24.25 | -18.55 | -68 | -70.5 | -89.24 | -182.81 | -556.17 | -906.3 | -817.01 | -153.35 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |